Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptid
NOVA2
Reaktivität: Human
Wirt: Synthetic
WB, BP
-
- Target Alle NOVA2 Produkte
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Western Blotting (WB), Blocking Peptide (BP)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-NOVA2 antibody (Catalog #: ARP40399_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
- Hintergrund
-
NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
Alias Symbols: ANOVA, NOVA3
Protein Size: 492 - Molekulargewicht
- 54 kDa
- Gen-ID
- 4858
- NCBI Accession
- NM_002516, NP_002507
- UniProt
- Q9UNW9
-
Sie sind hier:
